Home

LAI

Read time: 2 min

Congress highlights

Improving treatment adherence in patients with early-phase schizophrenia

Early treatment engagement and a robust treatment response in patients with schizophrenia may be a...

Alcohol Dependence, Schizophrenia

Read time: 3 min

Congress highlights

Decreasing relapse and rehospitalization in first-episode psychosis

More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder (...

Read time: 4 min

Congress highlights

Adherence in the real world

Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...

Read time: 4 min

Congress highlights

Long-acting injectables – functioning and compliance studies

Two posters presented during SIRS 2019 suggest that use of long-acting injectable (LAI)...

Read time: 1 min

Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...

Read time: 4 min

Congress highlights

Niche no more: early use of long-acting injectable antipsychotics in schizophrenia

It is well known that early treatment of schizophrenia leads to better patient outcomes in the long...

Bipolar, Schizophrenia

Read time: 4 min

Congress highlights

Antipsychotic treatment adherence improves functional outcome for bipolar I disorder and schizophrenia

A good functional outcome — improved cognition; ability to work, study, live independently,...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country